Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Eder

Showing results (41-50 of 117) with videos related to

Pageof 12
Sort By:
Physical Review Letters|August 25, 2018
Parity-Engineered Light-Matter InteractionJ Goetz, F Deppe, K G Fedorov, et al.
Cancer Research|December 18, 2003
Endostatin inhibits the vascular endothelial growth factor-induced mobilization of endothelial progenitor cellsGunter Schuch, John V Heymach, Masashi Nomi, et al.
Cancer|March 18, 2005
Phase I dose-escalation study of tezacitabine in combination with 5-fluorouracil in patients with advanced solid tumorsJohanna C Bendell, Joseph P Eder, Jeffrey W Clark, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Phase I trial of the colloidal dispersion formulation of 9-amino-20(S)-camptothecin administered as a 72-hour continuous intravenous infusionJ P Eder, J G Supko, T Lynch, et al.
Cancer Research|September 1, 1986
Prediction of the optimal timing of bone marrow reinfusion after high dose chemotherapyJ P Eder, R C Bast, W P Peters, et al.
Bone Marrow Transplantation|July 1, 1992
Pulmonary toxicity associated with high dose chemotherapy in the treatment of solid tumors with autologous marrow transplant: an analysis of four chemotherapy regimensM V Seiden, A Elias, L Ayash, et al.
Blood|December 1, 1990
Serum erythropoietin levels in patients receiving intensive chemotherapy and radiotherapyL Schapira, J H Antin, B J Ransil, et al.
Cancer Research|December 15, 1995
DNA topoisomerase II alpha expression is associated with alkylating agent resistanceJ P Eder, V T Chan, S W Ng, et al.
Cancer Treatment Reports|November 1, 1987
Pharmacokinetics of continuous-infusion high-dose thiotepaW D Henner, T C Shea, E A Furlong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1989
A phase I clinical and pharmacokinetic study of carboplatin and autologous bone marrow supportT C Shea, M Flaherty, A Elias, et al.
Pageof 12

Showing results (41-50 of 117) with videos related to

Sort By:
Pageof 12
Physical Review Letters|August 25, 2018
Parity-Engineered Light-Matter InteractionJ Goetz, F Deppe, K G Fedorov, et al.
Cancer Research|December 18, 2003
Endostatin inhibits the vascular endothelial growth factor-induced mobilization of endothelial progenitor cellsGunter Schuch, John V Heymach, Masashi Nomi, et al.
Cancer|March 18, 2005
Phase I dose-escalation study of tezacitabine in combination with 5-fluorouracil in patients with advanced solid tumorsJohanna C Bendell, Joseph P Eder, Jeffrey W Clark, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Phase I trial of the colloidal dispersion formulation of 9-amino-20(S)-camptothecin administered as a 72-hour continuous intravenous infusionJ P Eder, J G Supko, T Lynch, et al.
Cancer Research|September 1, 1986
Prediction of the optimal timing of bone marrow reinfusion after high dose chemotherapyJ P Eder, R C Bast, W P Peters, et al.
Bone Marrow Transplantation|July 1, 1992
Pulmonary toxicity associated with high dose chemotherapy in the treatment of solid tumors with autologous marrow transplant: an analysis of four chemotherapy regimensM V Seiden, A Elias, L Ayash, et al.
Blood|December 1, 1990
Serum erythropoietin levels in patients receiving intensive chemotherapy and radiotherapyL Schapira, J H Antin, B J Ransil, et al.
Cancer Research|December 15, 1995
DNA topoisomerase II alpha expression is associated with alkylating agent resistanceJ P Eder, V T Chan, S W Ng, et al.
Cancer Treatment Reports|November 1, 1987
Pharmacokinetics of continuous-infusion high-dose thiotepaW D Henner, T C Shea, E A Furlong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1989
A phase I clinical and pharmacokinetic study of carboplatin and autologous bone marrow supportT C Shea, M Flaherty, A Elias, et al.
Pageof 12